126 related articles for article (PubMed ID: 2669801)
1. Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy.
Richardson AJ; Higgins RM; Liddington M; Murie J; Ting A; Morris PJ
Transpl Int; 1989 Apr; 2(1):27-32. PubMed ID: 2669801
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute rejection episodes in dog renal allograft recipients receiving cyclosporin A:ATG vs prednisolone.
Kelly GE; Sheil AG
Aust N Z J Surg; 1986 Mar; 56(3):251-5. PubMed ID: 3521569
[TBL] [Abstract][Full Text] [Related]
3. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
4. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
6. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
[TBL] [Abstract][Full Text] [Related]
7. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
8. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
Cantarovich D; Karam G; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Le Normand L; Soulillou JP
Kidney Int; 1998 Oct; 54(4):1351-6. PubMed ID: 9767555
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.
Marfo K; Akalin E; Wang C; Lu A
Am J Health Syst Pharm; 2011 Dec; 68(23):2276-82. PubMed ID: 22095818
[TBL] [Abstract][Full Text] [Related]
12. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
Cantarovich D; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Lerat L; Moreau A; Soulillou JP
Nephrol Dial Transplant; 2000 Oct; 15(10):1673-6. PubMed ID: 11007839
[TBL] [Abstract][Full Text] [Related]
13. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
Ratcliffe PJ; Dudley CR; Higgins RM; Firth JD; Smith B; Morris PJ
Lancet; 1996 Sep; 348(9028):643-8. PubMed ID: 8782754
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
15. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
Sumpio BE; Dwyer JM; Flye MW
Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute cellular rejection in renal transplantation patients on ciclosporin with antithymocyte globulin.
Arndt R; Hammerer P; Huland E; Krämer-Hansen H; Huland H
Urol Int; 1988; 43(3):139-44. PubMed ID: 3051619
[TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.
Wechter WJ; Brodie JA; Morrell RM; Rafi M; Schultz JR
Transplantation; 1979 Oct; 28(4):294-302. PubMed ID: 388762
[TBL] [Abstract][Full Text] [Related]
18. Therapy of acute cadaveric renal allograft rejection with adjunctive antithymocyte globulin.
Filo RS; Smith EJ; Leapman SB
Transplantation; 1980 Dec; 30(6):445-9. PubMed ID: 7008293
[TBL] [Abstract][Full Text] [Related]
19. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
20. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]